C4C News Filter By Category
UW start-up EnVitrum turns trash glass into bricks; wins Phase II NSF SBIR of $500K to scale production
Posted on March 28, 2013
UW start-up EnVitrum has been awarded a phase II NSF SBIR of $500k for two years to perform development related to scaling up their...
Start-up company Lamprogen to join C4C Incubator
Posted on March 07, 2013
UW biomedical spin-out Lamprogen, founded by UW Professor of Chemistry Daniel Chiu, has joined the C4C New Ventures Facility (NVF). The NVF at Fluke...
UW Spin-out Impel Neuropharma Named a Top "Innovation in Medical Devices" by Seattle Business Magazine
Posted on March 04, 2013
UW Spin-out Impel Neuropharma, which has developed a unique nasal delivery device that utilizes direct “nose-to-brain” transport to improve drug delivery, was honored with...
Japanese drugmaker Takeda secures rights to lupus drugs from UW spinout Resolve Therapeutics in $255M deal
Posted on March 01, 2013
Takeda Pharmaceutical Company and Resolve Therapeutics today jointly announced that they have entered into a partnership to develop compounds for the treatment of lupus...
Join us on March 26 for a conversation with 8 leading start-up service providers
Posted on March 01, 2013
Every successful start-up needs competent service providers—from legal counsel and accounting to insurance and real estate professionals. Join us to learn about the types...
UW Professor Jim Olson's start-up company Blaze Bioscience Raises $8.5M to help surgeons pinpoint cancer with "tumor paint"
Posted on February 22, 2013
Seattle biotechnology start-up Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more easily identify cancer cells...